Verified peer comparison
CTO Realty Growth, Inc. Common Stock vs Allogene Therapeutics, Inc. Financial Comparison
CTO Realty Growth, Inc. Common Stock versus Allogene Therapeutics, Inc. using 2…
Direct answer
CTO Realty Growth, Inc. Common Stock and Allogene Therapeutics, Inc. are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free CTO Realty Growth, Inc. Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- CTO Realty Growth, Inc. Common Stock Revenue
- 149,545,000 USD
- Allogene Therapeutics, Inc. Revenue
- 0 USD
- CTO Realty Growth, Inc. Common Stock Operating income
- 33,080,000 USD
- Allogene Therapeutics, Inc. Operating income
- -206,933,000 USD